Načítá se...
Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial
BACKGROUND: Adults with bipolar disorder (BD) often experience neurocognitive impairment that negatively impacts functioning and quality of life. Previous trials have found that dopamine agonist agents improve cognition in healthy volunteers and that adults with BD who have stable mood and mild cogn...
Uloženo v:
| Vydáno v: | J Clin Psychopharmacol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238822/ https://ncbi.nlm.nih.gov/pubmed/33956703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001407 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|